Cambridge Antibody Technology

Type
Business expansion
Country
United Kingdom
Region
East (England); Cambridgeshire and Peterborough; Cambridgeshire CC
Location of affected unit(s)
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
300 jobs
Number of planned job creations
Job creation
Announcement Date
30 March 2007
Employment effect (start)
1 April 2007
Foreseen end date
31 December 2007

Description

An expanding biotechnology and medical firm is set to create 300 new jobs.

Cambridge Antibody Technology is also moving into a new building at the city's Milton Science Park.

The firm is a bio-pharmaceutical specialist developing human antibody therapies to improve the quality of life of seriously ill patients.

The workforce is set to double in size by 2008 when the firm moves to the new building where it will carry out both research and manufacturing.

Sources

  • 30 March 2007: BBC Website

Citation

Eurofound (2007), Cambridge Antibody Technology, Business expansion in United Kingdom, factsheet number 65187, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/65187.